跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,024 条关于
“Xoma Royalty Corp”
全部
7,024
临床试验
5,139
药物
474
机构
448
资讯
963
去年
ESSA Pharma Agrees to $1.91 Per Share Acquisition by XenoTherapeutics in Wind-Down Transaction
去年
Xoma Royalty Acquires Mural Oncology for $35.2-38.8M in Latest Biotech Liquidation Deal
9个月前
XOMA Royalty Completes $2.035 Per Share Acquisition of Mural Oncology
去年
XOMA Royalty Acquires Pulmokine for $20 Million, Expanding PAH Portfolio with Seralutinib
去年
XOMA Royalty Acquires Mural Oncology for $36.2 Million in Strategic Biotech Consolidation
去年
XOMA Royalty Corporation to Acquire Turnstone Biologics for $0.34 Per Share Plus Contingent Value Rights
去年
XOMA Royalty Reports Q3 2024 Financial Results, Highlights Portfolio Expansion
去年
XOMA Royalty Acquires $30 Million Mezagitamab Rights from BioInvent as Anti-CD38 Antibody Advances to Phase 3
去年
XOMA Royalty Reports Q3 2024 Financial Results, Highlights MIPLYFFA™ Approval
去年
Ligand Pharmaceuticals Leads $75M Royalty Financing for D-Fi Gene Therapy in Rare Skin Disease Trial
第 1 页,共 97 页
上一页
下一页